|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
ICD-10 (CM) Code and Descriptor
|
M79.3 |
Panniculitis, unspecified
|
M793 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 34.37%
|
18.68%
|
14.10%
|
9.82%
|
5.74%
|
4.02%
|
3.33%
|
2.12%
|
1.60%
|
1.08%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M79.3*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
567
|
569
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
511
|
519
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
497
|
497
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
459
|
1,607
|
|
80053
|
COMPREHEN METABOLIC PANEL |
368
|
368
|
|
J2405
|
ONDANSETRON HCL INJECTION |
356
|
1,649
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
307
|
1,404
|
|
J3010
|
FENTANYL CITRATE INJECTION |
288
|
600
|
|
J1170
|
HYDROMORPHONE INJECTION |
255
|
445
|
|
80048
|
METABOLIC PANEL TOTAL CA |
248
|
248
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
239
|
7,077
|
|
15830
|
EXC EXCESSIVE SKIN ABDOMEN |
232
|
232
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
191
|
839
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
185
|
397
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
182
|
1,241
|
|
J1644
|
INJ HEPARIN SODIUM PER 1000U |
177
|
1,725
|
|
97530
|
THERAPEUTIC ACTIVITIES |
173
|
254
|
|
83690
|
ASSAY OF LIPASE |
170
|
170
|
|
99284
|
EMERGENCY DEPT VISIT MOD MDM |
168
|
168
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
166
|
166
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M79.3 related to the following DRG Codes:
606-607
|
